Medicon Village
Scheelevägen 8
Lund 223 63
Sweden
46 4 62 75 60 00
https://www.immunovia.com
Settore/i:
Settore:
Impiegati a tempo pieno: 11
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Jeff Borcherding | Global Chief Executive Officer & President | N/D | N/D | 1973 |
Ms. Karin Almqvist Liwendahl | Chief Financial Officer | N/D | N/D | 1962 |
Dr. Karl Stone | Chief Operating Officer | N/D | N/D | 1963 |
Ms. Lara E. Sucheston-Campbell | Head of Clinical & Medical Affairs | N/D | N/D | N/D |
Immunovia AB (publ), a diagnostic company, develops and commercializes blood-based diagnostics for cancer in Sweden and internationally. It offers IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. The company was incorporated in 2007 and is headquartered in Lund, Sweden.
L'ISS Governance QualityScore di Immunovia AB (publ) al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.